Aktuellt
SENASTE
At SEB’s Nordic Seminar, CEO Ulrik Harryson answered questions centred around SyntheticMR’s journey towards becoming a standard of care. On the back of recent commercial initiates and the strong progress with the OEMs, we expect the recent strong growth momentum to continue in 2023. Overall, there was limited new incremental information shared at the session but our positive view on the financial outlook was reaffirmed.
LÄS MER
